Vita Coco CFO sells 4,000 company shares

Vita Coco Company, Inc.’s Chief Financial Officer Corey Baker reported open-market sales of company common stock.

Rhea-AI Filing Summary

Vita Coco Company, Inc.’s Chief Financial Officer Corey Baker reported open-market sales of company common stock. On March 17, 2026, he sold 2,000 shares at $59.92 per share, followed by another 2,000 shares at $58.04 per share on March 18, 2026, for total reported sales of 4,000 shares.

After these transactions, Baker directly holds 27,951 shares of common stock. He also holds multiple non-qualified stock options to purchase additional common shares with exercise prices ranging from $16.91 to $33.36. The filing notes that the stock sales were carried out under a Rule 10b5-1 trading plan, indicating they were pre-arranged.

Insider Trade Summary 10b5-1

Net Seller: 4,000 shares

Net Sell 7 txns

Insider BAKER COREY

Role Chief Financial Officer

Sold 4,000 shs ($236K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,000	$58.04	$116K
Sale	Common Stock	2,000	$59.92	$120K
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--
holding	Non-Qualified Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Common Stock — 27,951 shares (Direct); Non-Qualified Stock Option (Right to Buy) — 56,197 contracts (Direct)

Footnotes (5)

1. F1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. F2. The stock option vests in four equal annual installments beginning on March 10, 2024.
3. F3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
4. F4. The stock option vests in four equal annual installments beginning on March 4, 2025.
5. F5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vita Coco (COCO) disclose for Corey Baker?

Vita Coco disclosed that CFO Corey Baker sold 4,000 shares of common stock in open-market transactions. He sold 2,000 shares at $59.92 on March 17, 2026 and 2,000 shares at $58.04 on March 18, 2026.

How many Vita Coco (COCO) shares does the CFO hold after these sales?

After the reported sales, CFO Corey Baker directly holds 27,951 shares of Vita Coco common stock. This figure reflects his position following the two open-market transactions disclosed for March 17 and March 18, 2026 in the Form 4 filing.

Were Vita Coco (COCO) CFO Corey Baker’s stock sales pre-planned?

Yes. The filing states the sales of Vita Coco common stock were effected pursuant to a Rule 10b5-1 trading plan. Such plans are pre-arranged trading programs that allow insiders to sell shares according to predetermined criteria, reducing discretion over trade timing.

What prices did Vita Coco (COCO) CFO Corey Baker receive for the sold shares?

Corey Baker sold 2,000 Vita Coco common shares at $59.92 per share on March 17, 2026, and another 2,000 shares at $58.04 per share on March 18, 2026. Both transactions were classified as open-market sales in the Form 4.

What stock options does the Vita Coco (COCO) CFO still hold?

The CFO holds several non-qualified stock options to buy Vita Coco common stock. These options cover underlying shares at exercise prices of $16.91, $24.35, $26.18, $27.59 and $33.36, with expiration dates between 2033 and 2035, and are held directly.

Does the Vita Coco (COCO) Form 4 show any option exercises by the CFO?

No option exercises are reported in this Form 4. The derivative entries reflect existing non-qualified stock option holdings, with underlying share amounts and exercise prices listed, but the summarized transaction data show only open-market stock sales and no option exercises.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/19/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAKER COREY

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NEW YORK 10003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		S(1)		2,000	D	$59.92	29,951	D
Common Stock	03/18/2026		S(1)		2,000	D	$58.04	27,951	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$16.91							(2)	03/10/2033	Common Stock	9,205		9,205	D
Non-Qualified Stock Option (Right to Buy)	$24.35							(3)	05/10/2033	Common Stock	13,481		13,481	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(4)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (Right to Buy)	$27.59							(3)	08/07/2033	Common Stock	11,547		11,547	D
Non-Qualified Stock Option (Right to Buy)	$33.36							(5)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The stock option vests in four equal annual installments beginning on March 10, 2024.

3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.

4. The stock option vests in four equal annual installments beginning on March 4, 2025.

5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	/s/ Alison Klein, attorney-in-fact for Corey Baker	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)